Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BC Biotech (Zhejiang BC Biotech), also known as Parkin Biotech, is a synthetic biology company that focuses on the development of high-performance bio-based materials and functional proteins. The company leverages a proprietary synthetic biology platform to engineer proteins and microorganisms for applications in medical aesthetics, wound healing, and skin care. Its pipeline includes recombinant protein adhesives, bio-based functional ingredients like ergothioneine, and materials for drug delivery. BC Biotech has attracted significant venture capital from investors such as IDG Capital and Matrix Partners China to scale its bio-manufacturing capabilities and expand its product portfolio into clinical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BC Biotech.